FDA Inspection 1314802 — Todd E. Schlesinger, MD
The FDA completed an inspection of Todd E. Schlesinger, MD on April 22, 2026 in Charleston, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 22, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Charleston, SC (United States)
Additional Details
Clinical Investigator (CI)